- Chart
- Upturn Summary
- Highlights
- Valuation
- About
SRx Health Solutions Inc. (SRXH)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/18/2025: SRXH (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -55.42% | Avg. Invested days 26 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.47 - 3.15 | Updated Date 06/14/2025 |
52 Weeks Range 0.47 - 3.15 | Updated Date 06/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
SRx Health Solutions Inc.
Company Overview
History and Background
SRx Health Solutions Inc. is a privately held company that provides integrated healthcare solutions. While specific founding details and a comprehensive history are not publicly available due to its private status, it has evolved to offer a range of services aimed at improving patient outcomes and healthcare efficiency. Significant milestones likely involve expansions in service offerings and geographical reach within the US healthcare market.
Core Business Areas
- Specialty Pharmacy Services: SRx Health Solutions Inc. focuses on providing specialized pharmacy services, including dispensing complex medications, patient education, adherence programs, and support for chronic and rare diseases. This segment addresses the unique needs of patients requiring high-cost or complex treatment regimens.
- Infusion Services: The company offers home and alternate-site infusion services, delivering intravenous medications and therapies in a patient's home or at designated infusion centers. This includes managing conditions requiring injectable or infusible treatments.
- Chronic Care Management: SRx Health Solutions Inc. engages in programs designed to manage patients with chronic conditions, aiming to reduce hospitalizations and improve overall health through coordinated care and ongoing support.
Leadership and Structure
As a privately held entity, specific details regarding the leadership team and detailed organizational structure are not publicly disclosed. Typically, such companies are led by a CEO and a board of directors or advisors, with departments managing operations, clinical services, finance, and patient care.
Top Products and Market Share
Key Offerings
- Specialty Pharmacy Dispensing: SRx Health Solutions Inc. dispenses a wide array of specialty medications for conditions such as oncology, autoimmune diseases, hepatitis C, and rare genetic disorders. Market share data for individual product lines is not publicly available. Key competitors in this space include McKesson Specialty Pharmacy, Cardinal Health, Cigna (Express Scripts), CVS Health (Caremark).
- Home Infusion Therapy: Provides administration of IV therapies for various conditions including pain management, IV antibiotics, hydration, and nutritional support. Market share is fragmented and difficult to ascertain for specific service providers. Competitors include Option Care Health, Infu-Med, and various regional home health agencies offering infusion services.
Market Dynamics
Industry Overview
The US healthcare industry, particularly the specialty pharmacy and home infusion segments, is characterized by increasing demand due to an aging population, the rising prevalence of chronic diseases, and advancements in biopharmaceuticals. The industry is highly regulated and influenced by payer policies, drug pricing, and technological innovation. There's a growing trend towards value-based care and a shift of care from hospitals to home settings.
Positioning
SRx Health Solutions Inc. positions itself as a provider of comprehensive, patient-centric healthcare solutions, focusing on complex therapies and chronic disease management. Its competitive advantage likely lies in its integrated approach, combining specialty pharmacy with infusion services, and a commitment to personalized patient care and adherence support. By offering both dispensing and administration, it can potentially provide a more seamless experience for patients and providers.
Total Addressable Market (TAM)
The TAM for specialty pharmacy services in the US is estimated to be over $300 billion and growing, while the home infusion market is valued at tens of billions of dollars. SRx Health Solutions Inc. operates within these substantial markets, aiming to capture a significant portion through its specialized offerings and integrated care model. Its positioning is focused on a niche within these markets, emphasizing complex and chronic care.
Upturn SWOT Analysis
Strengths
- Integrated service offering (specialty pharmacy and infusion)
- Focus on patient-centric care and adherence programs
- Expertise in managing complex and chronic conditions
- Potential for strong relationships with healthcare providers and payers
Weaknesses
- Limited public information due to private status
- Scalability challenges compared to larger public entities
- Reliance on payer reimbursements and regulatory changes
- Brand recognition may be lower than major public players
Opportunities
- Growing demand for home-based healthcare services
- Advancements in biopharmaceuticals requiring specialized handling
- Expansion into new therapeutic areas and geographical markets
- Partnerships with pharmaceutical manufacturers and integrated health systems
Threats
- Intense competition from larger established players
- Increasing drug costs and payer scrutiny on pricing
- Changes in healthcare policy and reimbursement rates
- Cybersecurity risks and data privacy concerns
Competitors and Market Share
Key Competitors
- McKesson Corporation (MCK)
- Cardinal Health, Inc. (CAH)
- CVS Health Corporation (CVS)
- UnitedHealth Group Incorporated (UNH)
- Option Care Health, Inc. (OPCH)
Competitive Landscape
SRx Health Solutions Inc. faces a highly competitive landscape dominated by large, publicly traded corporations with extensive resources and established market presence. While the company focuses on a specialized niche, its ability to compete depends on its agility, the quality of its patient care, and its ability to secure favorable contracts with payers and providers. Its integrated approach is a key differentiator against more narrowly focused competitors.
Growth Trajectory and Initiatives
Historical Growth: While specific historical growth figures are not public, it is reasonable to assume that SRx Health Solutions Inc. has experienced growth in line with the expansion of the specialty pharmacy and home infusion markets it serves. This growth would be driven by increasing patient populations requiring these services and strategic business development.
Future Projections: Future projections for SRx Health Solutions Inc. are not publicly available. However, the company is positioned to benefit from ongoing trends in healthcare, including the shift towards home-based care and the increasing need for specialized medication management.
Recent Initiatives: Specific recent initiatives are not publicly disclosed. However, companies in this sector often focus on expanding service lines, forming strategic partnerships, adopting new technologies for patient management, and enhancing operational efficiency.
Summary
SRx Health Solutions Inc. operates in the growing specialty pharmacy and home infusion markets, offering integrated patient-centric care. Its strengths lie in its specialized services and focus on chronic conditions. However, as a private entity, it lacks public financial transparency, which can be a weakness. The company must navigate intense competition and evolving healthcare regulations to capitalize on opportunities in home-based care and pharmaceutical advancements.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Industry reports and market analysis firms
- General knowledge of the healthcare sector
- Publicly available information on competitors
Disclaimers:
This analysis is based on publicly available information and general industry knowledge. As SRx Health Solutions Inc. is a privately held company, detailed financial and operational data is not accessible, leading to assumptions and limitations in the analysis. This information is for informational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About SRx Health Solutions Inc.
Exchange NYSE MKT | Headquaters Toronto, ON, Canada | ||
IPO Launch date 2017-09-22 | CEO & Director Mr. Adesh A. Vora Pharm.D. | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 444 | Website https://srxhealth.ca |
Full time employees 444 | Website https://srxhealth.ca | ||
SRx Health Solutions Inc. provides healthcare and medical treatment services. It provides compounding services, pharmacy services, nursing healthcare, clinic services, vaccination services, caring for diabetes patients, travel health, compounding services, TB testing, and human immunodeficiency virus prevention services. The company also operates retail-owned pharmacies. In addition, it provides COVID-19 testing services. The company was founded in 2013 and is based in Toronto, Canada. It has additional locations in Canada and London, the United Kingdom.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

